EIT Health accelerates Italian startups

SurgiQ, an Italian start-up specialized in helping public and private hospitals to better plan their activities and which received mentoring and financial support in this year's EIT Health Headstart program, has just concluded an equity financing operation for an amount of 410 thousand euros to further develop their solution, the Q-planner, an automated tool based on artificial intelligence.

The purpose of the solution is to save time for hospitals in the efficient allocation of resources. The operation, which has a strong industrial connotation, is the result of a collaboration between Digital Magics, which contributed with an investment of 100 thousand euros, and CDP Venture Capital Sgr - National Innovation Fund through the AccelerORA! of the Accelerators Fund, which invested a sum of 150,000 euros.

In addition, the financing round was followed by a series of private healthcare entrepreneurs under the guidance of Michele Nicchio, president of AIOP Giovani, the young entrepreneurs section of the National Association of Private Healthcare Companies. SurgiQ has raised a total of around € 1 million in investments over the past 4 years from a range of players, including healthcare entrepreneurs.

«This unique combination of financial and industrial investors, some of whom are already ours customers, will fuel our growth, ”said Ivan Porro, CEO of SurgiQ. «We are proud of this new investment» commented Chiara Maiorino, Regional Manager South Europe, Eit Health InnoStars «because it confirms the value we had seen in the company and which we had awarded with the EIT Health Headstart grant. We are happy to see that SurgiQ was able to benefit from the grant to exploit its potential ».

SurgiQ simplifies and optimizes the management of care paths, thanks to a unique approach to visualization and traceability of data and the use of Artificial Intelligence for the automatic planning of critical resources (operating rooms, gyms, beds , staff, etc.).

During 2020 the start-up was able to support its customers by releasing specific features for Covid, to help them manage care correctly and easily plan resources, reducing blocks caused by the pandemic to a minimum.

The company will also use the loan to strengthen strategic partnerships with the University of Genoa - DIBRIS, and with an important pharmaceutical company, for the development of new product.